132.98
-0.54
(-0.40%)
At close: April 17 at 9:50:05 PM GMT+2
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 17 | 17 |
| Avg. Estimate | -- | -- | 15.7B | 16.71B |
| Low Estimate | -- | -- | 15.04B | 16.2B |
| High Estimate | -- | -- | 16.09B | 17.22B |
| Year Ago Sales | -- | -- | 14.8B | 15.7B |
| Sales Growth (year/est) | -- | -- | 6.09% | 6.42% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CSJ.F | -- | -- | -- | -- |
| S&P 500 | 7.04% | 5.20% | 8.89% | 14.14% |
Related Tickers
BT3.BE Lineage Cell Therapeutics Inc
0.3600
-1.10%
HQ1.MU Oruka Therapeutics Inc. R
7.50
+2.04%
MVR0.BE Medivir AB
0.1372
-2.42%
05Y.MU Vivoryon Therapeutics NV
1.7140
0.00%
PROT Proteonomix, Inc.
0.0000
0.00%
ICY.HA Incyte Corp
51.16
-0.31%
DBV.F DBV Technologies S.A.
1.2520
+1.79%
HTD.MU Corcept Therapeutics Inc
57.90
-3.60%
96X.F FluoGuide A/S
3.1700
0.00%
4FR.BE Faron Pharmaceuticals Oy
2.4400
+6.09%